The American Physiological Society (APS) and InsideScientific are pleased to announce a joint webinar series focused on providing the next-generation scientists with the necessary tools to succeed in science, specifically the skillsets and key tools that are most relevant in today’s modern world.

As you approach the conclusion of your pre- or post-doctoral work, you are probably asking, “What should my next step be and how do I get there?” Two oft-mentioned career choices are “Academia” or “Industry”. While both career types can be fulfilling and rewarding, when preparing for this next position it is important to realize that there are similarities and differences that you need to be aware of in order to be successful. We will discuss several of these areas related to how to prepare yourself for a career transition, including building your CV/resume, networking, crafting your online presence, how and where to search for jobs, as well as some basic differences between academia and industry. Dr. Gumz and Dr. Northcott will provide some insights and thoughts on how to both survive and thrive in the current academic and industry environment.

Presenters

Associate Professor of Medicine, Director
MD-Nephrology
University of Florida

Gumz is an associate professor of medicine at the University of Florida (UF) where she also serves as an associate director for the Center for Integrative Cardiovascular and Metabolic Disease. She earned her PhD in biochemistry and molecular biology from UF in 2004 and later joined the faculty after completing postdoctoral training in renal physiology. Gumz served four years as treasurer for the APS Renal Section and has been a member of the APS Women in Physiology and Science Policy committees. Gumz currently serves as an associate editor for the American Journal of Physiology-Renal Physiology. Gumz and her laboratory study the role of the molecular circadian clock in the kidney and its contribution to blood pressure regulation and renal function.

Director and Research Project Lead
Digital Medicine and Translational Imaging group in Early Clinical Development
Pfizer

Carrie Northcott, PhD is a director and research project lead within the Digital Medicine and Translational Imaging (DMTI) group in Early Clinical Development (ECD) at Pfizer, located in Cambridge, MA. She leads a diverse team that is evaluating and validating the use of wearable digital devices to more fully understand and characterize physiological endpoints, such as quantitatively measuring nighttime scratch and sleep. Northcott has a diverse scientific background in pharmacology, toxicology, and physiology which provides unique insight into understanding how these endpoints provide meaningful information to patients, doctors and researchers to better treat and understand diseases. Northcott received her PhD in pharmacology and toxicology from Michigan State University and her master’s and bachelor of science degrees in agricultural sciences/agronomy from the University of Illinois. She has published numerous scientific publications in various fields of scientific study and is actively involved in various scientific societies and volunteers within the community.

Additional Content From American Physiological Society

Why is Bariatric Surgery So Effective?

Why is Bariatric Surgery So Effective?

In this final installment of our Obesity 2020 webinar series, Dr. Lee Kaplan will discuss late-breaking research and review various mechanisms of action of bariatric and metabolic surgery and how they affect the regulation of energy balance and metabolic function.

Related Content

Open Access: What Researchers Need to Know Now

Open Access: What Researchers Need to Know Now

Industry professionals define what it means to publish Open Access, the different types, factors that influence funding, and share how to manage related fees from grants and budgets in several examples.